Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD
Conditions: Non-Alcoholic Fatty Liver Disease; Type2diabetes Interventions: Drug: Empagliflozin 10 MG; Drug: Pioglitazone 15mg; Drug: Metformin Sponsor: Jinnah Postgraduate Medical Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials
The Neuroendocrine Effects of Pioglitazone in Patients With Lung Cancer and Cachexia
Condition: Lung Cancer Interventions: Drug: Pioglitazone 45 mg; Drug: Placebo Sponsor: Pennington Biomedical Research Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2023 Category: Research Source Type: clinical trials